Everomus 0.25 mg Tablet
8.50$
6.06$
Everomus 0.25 mg Tablet is a targeted anticancer therapy specifically designed to combat various advanced malignancies, including pancreatic, gastric, intestinal, and lung cancers that are inoperable. This medication is particularly effective for postmenopausal women battling hormone receptor-positive, HER2-negative breast cancer, providing a vital treatment option when other therapies are not suitable. Everolimus works by inhibiting a key protein involved in cell growth and proliferation, thus slowing down tumor progression. Additionally, it is indicated for adult patients with advanced renal cell carcinoma who have not responded to treatments like sunitinib or sorafenib. Patients should be aware of potential side effects, including risk of infection and changes in liver function, necessitating regular monitoring during treatment. Everomus represents a crucial advancement in oncology, offering hope to those with challenging cancer diagnoses. Always consult with a healthcare professional before starting treatment to ensure it aligns with your individual health needs.
الكمية
Active Pharmaceutical Ingredient
Uses
• Everomus 0 25 mg tablet is primarily utilized in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women. It is often prescribed in conjunction with exemestane after previous treatments with letrozole or anastrozole have failed. This combination therapy aims to help manage cancer progression effectively. Patients may experience various symptoms, including changes in breast appearance and unexplained weight loss, which Everomus helps address.
• The medication is also indicated for the treatment of neuroendocrine tumors (NET), which are rare and can develop in various organs such as the lungs and pancreas. Everomus 0 25 mg tablet aids in controlling the growth of these tumors, providing a therapeutic option for patients with limited treatment alternatives. By targeting the underlying mechanisms of tumor growth, it assists in managing this complex condition. Patients with NET may benefit significantly from this targeted therapy.
• Everomus 0 25 mg tablet is effective in treating adult patients with kidney cancer who have not responded to prior treatments like sunitinib or sorafenib. It works by inhibiting pathways that promote cancer cell growth, thereby helping to stabilize the disease. Symptoms such as fatigue, weight loss, and swelling may improve with this treatment. The use of Everomus is essential for enhancing the quality of life in these patients.
• Additionally, Everomus 0 25 mg tablet is indicated for patients with Tuberous Sclerosis Complex (TSC) who have renal angiomyolipoma that does not require immediate surgical intervention. This medication helps reduce the size of the tumors and manage associated symptoms. In pediatric and adult patients with TSC, Everomus can provide a significant benefit in the ongoing management of their condition. It is a critical part of a comprehensive treatment plan for these patients.
Benefits
Everomus 0.25 mg Tablet is indicated to patients dealing with various cancers such as breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Everolimus Tablet 0.25 mg travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreasing the activity of the immune system of the body and prevents the rejection of the transplanted organ. Everomus 0.25 mg works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumours in the brain or kidneys.
Side Effects
Everomus 0.25 mg Pack may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Infection
• Urinary issues
• Hypertension, rise in cholesterol or triglycerides
• Stomach pain, nausea, diarrhoea and/or constipation
• Headache
• Swelling in your legs or feet
Common Side Effects
• Swelling in legs and feet
• Blood in stools and urine
• Burning sensation during urination
• Mouth sores
• Headache
• Tiredness
• Nausea
How To Use
Everomus Tablet can be taken by mouth with or without food. Swallow the whole tablet with a glass of water. Do not crush, break, or chew the tablets. Take your dose around the same time every day. It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed. If you miss a dose and it has been less than 6 hours since your regular dose time, take it as soon as you remember. If it has been more than 6 hours, skip the dose. Do not take 2 doses at once to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Everomus Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Everomus 0.25 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Everomus 0.25 mg is recommended.
• Breastfeeding: It is not recommended to breastfeed while taking Everomus 0.25 mg. Anti-cancer Drug Everomus may pass into breast milk and harm the infant. If you are breastfeeding and taking Everolimus Tablet 0.25 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Everolimus Tablet 0.25 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Everomus 0.25 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Everomus 0.25 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Everolimus Tablet 0.25 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-cancer Drug Everomus during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Everomus 0.25 mg Pack may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Everomus 0.25 mg Pack.